Molecular Imaging News and Research

RSS

Canary Foundation to implement biosensor technologies for early cancer detection

Canary Foundation has committed to being the first organization to implement the breakthrough in biosensor technologies in its research pipeline. The new technology promises to revolutionize the early detection cancer field.

12 Oct 2009

White House honors PET researcher with National Science Award

Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, is being recognized by the White House with the National Medal of Science-the highest award for lifetime achievement in science. Eight other researchers will join Fowler to receive the award at a White House ceremony on October 7.

8 Oct 2009

ABT Molecular Imaging secures $9 million through its Series A financing

ABT Molecular Imaging, a medical imaging company developing a production platform to generate unit doses of molecular imaging drugs, announced today it has secured a $9 million round of financing.

7 Oct 2009

SNM's joint session with CMOD on molecular imaging biomarkers in clinical research

SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19th, 2009.

3 Oct 2009

New molecular imaging technique raises hope for common malignant female tumor

A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. This research was presented in a study published in the October issue of The Journal of Nuclear Medicine.

1 Oct 2009

Increment in 2010 PET reimbursement may increase the demand for Cardiac PET imaging

Positron Corporation, a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an increase in PET reimbursement of 22%, issued by the Centers for Medicare & Medicaid Services (CMS).

28 Sep 2009

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.

25 Sep 2009

Pakistan cardiology institute purchases Positron's Pulse compact digital cardiac camera

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announces the sale of a Pulse CDCC camera to CPE Institute Of Cardiology in Multan, Pakistan.

25 Sep 2009

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new ReninSense680(TM) FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.

24 Sep 2009

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.

23 Sep 2009

New Fluorescence Molecular Tomography imaging systems from VisEn Medical

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system -- the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.

23 Sep 2009

Philips and Bruker sign MOU to develop new imaging technology

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation, today announced that they have signed a memorandum of understanding (MOU) for the development of Magnetic Particle Imaging (MPI) scanners, a new imaging technology, for the preclinical market.

From Philips Healthcare 23 Sep 2009

ART's new generation Optix MX3 optical molecular imaging system unveiled

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today unveiled a new generation of its optical molecular imaging system, called Optix® MX3, at the Industry Workshop opening event of the World Molecular Imaging Congress.

23 Sep 2009

ESMO recognises outstanding achievements of leading cancer specialists

The European Society for Medical Oncology (ESMO) has recognized the outstanding achievements of three leading cancer specialists with its three prestigious annual awards: the 2009 ESMO Award, Hamilton Fairley Award and ESMO Lifetime Achievement Award.

23 Sep 2009

Gamma Medica-Ideas closes $24 million financing to support digital technologies

Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it had closed a $24 million financing, the company's first institutional round, in order to support continued growth of the company's proprietary digital SPECT, PET and CT technologies in current and new markets.

23 Sep 2009

ART to report on its molecular imaging products research at the World Molecular Imaging Congress

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at poster sessions at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009.

22 Sep 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

19 Sep 2009

Lantheus commences Phase 1 study evaluating novel LMI1195 heart failure imaging agent

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.

17 Sep 2009

Zevalin radioimmunotherapy drug approved for treating non-Hodgkin's lymphoma

SNM applauds the U.S. Food and Drug Administration's (FDA) recent decision to approve the radioimmunotherapy (RIT) drug, Zevalin, as a front-line treatment of non-Hodgkin's lymphoma (NHL).

11 Sep 2009

SNM survey evaluates the impact of the worldwide medical isotope shortage

SNM recently conducted a survey of nuclear pharmacies-pharmacies that supply the critical radioisotope Technetium-99m, which is used in more than 16 million nuclear medicine tests each year in the United States-to assess, anecdotally, the impact of the worldwide medical isotope shortage. According to the survey, 60 percent of radiopharmacies have been impacted by the most recent shortage. Technetium-99m is a product of Molybdenum-99, which has been in short supply recently.

9 Sep 2009

Molecular Imaging News and Research

Canary Foundation to implement biosensor technologies for early cancer detection

White House honors PET researcher with National Science Award

ABT Molecular Imaging secures $9 million through its Series A financing

SNM's joint session with CMOD on molecular imaging biomarkers in clinical research

New molecular imaging technique raises hope for common malignant female tumor

Increment in 2010 PET reimbursement may increase the demand for Cardiac PET imaging

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Pakistan cardiology institute purchases Positron's Pulse compact digital cardiac camera

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

New Fluorescence Molecular Tomography imaging systems from VisEn Medical

Philips and Bruker sign MOU to develop new imaging technology

ART's new generation Optix MX3 optical molecular imaging system unveiled

ESMO recognises outstanding achievements of leading cancer specialists

Gamma Medica-Ideas closes $24 million financing to support digital technologies

ART to report on its molecular imaging products research at the World Molecular Imaging Congress

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Lantheus commences Phase 1 study evaluating novel LMI1195 heart failure imaging agent

Zevalin radioimmunotherapy drug approved for treating non-Hodgkin's lymphoma

SNM survey evaluates the impact of the worldwide medical isotope shortage

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News